On-Demand DCT Webinars
-
A Multi-Disciplinary Perspective On Decentralized Study Design
7/1/2021
The biopharmaceutical industry is rapidly adopting methodologies that decentralize research by harnessing transformative data acquisition and patient engagement thus taking the research beyond the walls of the legacy study setting. To truly realize the promise of decentralized research models, a dynamic array of technological capabilities, traditional research core competencies, and innovative study design expertise is required. Join us as we explore operational challenges, technical solutions, and design considerations.
-
Leveraging Analytics To Improve Data Quality And Increase Enrollment In Decentralized Clinical Trials
7/1/2021
As clinical research is increasingly moving to a decentralized model, it’s critical that the patient matching and enrollment process is streamlined and data-driven to speed the clinical trial process. This webinar discusses how leveraging a data-driven approach to patient recruitment and enrollment allows sponsors of clinical research to overcome these challenges and accelerate their trial timelines.
-
Trials And Tribulations Of Electronic Patient Consent: Removing Barriers To eConsent Adoption
6/3/2021
After a decade of dabbling with eConsent, how can sponsors and technology providers meet the demand to bring clinical trials directly to the patient at a global scale? In this webinar, you’ll learn strategies to overcome the persistent challenges in eConsent adoption and gain the benefits promised from successful decentralized trials with remote capabilities for patients and sites.
-
Will Patient Engagement Be A Challenge In Decentralized Trials?
4/14/2021
In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb discuss interactions with patients when they are not engaging with nurses and physicians in-person during visits to clinics.
-
Can We Effectively Track Data In Decentralized Clinical Trials?
4/14/2021
In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb, discuss study patients being monitored from their homes and whether that creates challenges for sponsor companies having to track that data.
-
Highlight Reel: Virtual Site Training In Clinical Trials - The New Standard
3/24/2021
Before 2020, most study training provided to clinical research sites relied heavily on monitors doing training at initiation visits, and web-based on-demand training was a novel concept used by only a few forward-thinking sponsors. When the COVID-19 pandemic hit, web-based on-demand training became a must-have, not a nice-to-have. Don't have time to watch the full Virtual Site Training webinar? Check out our 10-minute webinar highlight reel to learn more about the differences between in-person and on-demand training, and the benefits of virtual training.
-
Virtual Site Training In Clinical Trials: The New Standard
3/24/2021
Before 2020, most study training provided to clinical research sites relied heavily on monitors doing training at initiation visits, and web-based on-demand training was a novel concept used by only a few forward-thinking sponsors. When the COVID-19 pandemic hit, web-based on-demand training became a must-have, not a nice-to-have. In this on-demand webinar, learn how combining on-demand training with web-based meetings has become the new training best practice for clinical trials.
-
Hindsight Is So 2020: Getting Ahead Of CNS Trial Enrollment In A Rapidly Changing Clinical Landscape
12/11/2020
The past six months have highlighted both existing and unexpected enrollment challenges, as sponsors, CROs, and sites have been pressed to evolve their recruitment strategies. Join the webinar to hear experts discuss their approach to adapting CNS trial enrollment to a rapidly changing clinical landscape.
-
Speed vs Safety: How Regulators Are Sizing Up Evidence Today
11/19/2020
In drug development, there is always pressure to move quickly, and with today’s push to develop treatments and vaccines for COVID, those pressures are exacerbated. In this webinar, the speakers will ground their predictions for the future in the historic response of regulatory bodies to epidemics, then explore recent shifts in the regulatory environment in response to COVID and the resulting new efficiencies in drug development.
-
Mitigating Covid-19 Through A Hybrid Decentralized Clinical Trials Approach
10/15/2020
The covid-19 pandemic has presented the industry with many risks and challenges to the management of clinical trials. In this webinar, we will discuss what risks and challenges COVID-19 has presented, ways in which these can be addressed.